Jane Kiselgof

Jane Kiselgof is an accomplished legal professional specializing in intellectual property within the pharmaceutical and biotechnology sectors. Currently serving as Senior Patent Counsel at Genentech since July 2024, Kiselgof previously held the position of Director of Intellectual Property at Carmot Therapeutics, Inc. and Intercept Pharmaceuticals between September 2023 and September 2023, and from August 2016 to September 2023, respectively. Earlier career experience includes roles as a Patent Agent at Cooley LLP and Aptalis Pharma from October 2014 to August 2016 and November 2011 to August 2014, respectively. Kiselgof holds a Doctor of Law (JD) degree from Rutgers Law School and a Ph.D. in Organic Chemistry from Brandeis University.